Xbrane Biopharma AB (XBRANE.ST) Q4 2024 Earnings

24OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-3.31
-2.21
-1.11
-0

Details

Expected EPS
-0.00461198648288
Actual EPS
-0.02992744361040832
Surprise EPS
-0.03
Surprise Percent
+548.91%

Description

Xbrane Biopharma AB (XBRANE.ST) has reported earnings of -0.02992744361040832 per share for Q4 2024.

0 Comments

Share your thoughts